Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
Chemistry & Biology
|
June 30, 2015
Nuclear Localization and Gene Expression Modulation by a Fluorescent Sequence-Selective p-Anisyl-benzimidazolecarboxamido Imidazole-Pyrrole Polyamide
Konstantinos Kiakos, Luke Pett, Vijay Satam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2015
The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)
Francesca Vena, Eleonora Li Causi, Manuel Rodriguez-Justo, et al.
Molecular Cancer Therapeutics
|
October 5, 2013
Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expression
Jaishree Bhosle, Konstantinos Kiakos, Andrew C G Porter, et al.
Clinical Cardiology
|
January 26, 2016
Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial
Robin Chung, Angshuman Maulik, Ashraf Hamarneh, et al.
Nature Communications
|
June 13, 2015
WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway
Alejandra Tomas, Simon O Vaughan, Thomas Burgoyne, et al.
Oncology Reports
|
March 10, 2005
Expression of c-kit (CD117) in neuroendocrine tumours--a target for therapy?
Virginia Kostoula, Korsa Khan, Kay Savage, et al.
Cancers
|
February 24, 2024
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies
Umair Mahmood, Elisya Muhamad Faizul, Sarah Howlett, et al.
Cancers
|
December 2, 2020
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience
Nalinie Joharatnam-Hogan, William Wilson, Kai Keen Shiu, et al.
Molecular Cancer Therapeutics
|
March 1, 2006
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment
Benjamin J Friedmann, Martyn Caplin, Boris Savic, et al.
Blood
|
June 19, 2002
Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma
Victoria J Spanswick, Charles Craddock, Mallika Sekhar, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
Chemistry & Biology
|
June 30, 2015
Nuclear Localization and Gene Expression Modulation by a Fluorescent Sequence-Selective p-Anisyl-benzimidazolecarboxamido Imidazole-Pyrrole Polyamide
Konstantinos Kiakos, Luke Pett, Vijay Satam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2015
The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)
Francesca Vena, Eleonora Li Causi, Manuel Rodriguez-Justo, et al.
Molecular Cancer Therapeutics
|
October 5, 2013
Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expression
Jaishree Bhosle, Konstantinos Kiakos, Andrew C G Porter, et al.
Clinical Cardiology
|
January 26, 2016
Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial
Robin Chung, Angshuman Maulik, Ashraf Hamarneh, et al.
Nature Communications
|
June 13, 2015
WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway
Alejandra Tomas, Simon O Vaughan, Thomas Burgoyne, et al.
Oncology Reports
|
March 10, 2005
Expression of c-kit (CD117) in neuroendocrine tumours--a target for therapy?
Virginia Kostoula, Korsa Khan, Kay Savage, et al.
Cancers
|
February 24, 2024
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies
Umair Mahmood, Elisya Muhamad Faizul, Sarah Howlett, et al.
Cancers
|
December 2, 2020
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience
Nalinie Joharatnam-Hogan, William Wilson, Kai Keen Shiu, et al.
Molecular Cancer Therapeutics
|
March 1, 2006
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment
Benjamin J Friedmann, Martyn Caplin, Boris Savic, et al.
Blood
|
June 19, 2002
Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma
Victoria J Spanswick, Charles Craddock, Mallika Sekhar, et al.
Page
of 7